Monoclonal Antibodies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibodies stocks.

Monoclonal Antibodies Stocks Recent News

Date Stock Title
Jul 1 AZN AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
Jul 1 MRUS Merus names Fabian Zohren as chief medical officer
Jul 1 MRUS Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
Jul 1 AZN AstraZeneca COVID prevention antibody gets EU fast-track review
Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
Jul 1 AZN Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 29 XOMA XOMA Corporation: A Hold Rating With Steady Income From Preferred Shares
Jun 28 XOMA XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains
Jun 28 REGN What's Going On With Regeneron Pharmaceuticals Stock On Friday?
Jun 28 AZN Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Jun 28 REGN Regeneron lymphoma antibody drug endorsed for conditional approval in EU
Jun 28 REGN Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
Jun 28 BIIB Biogen, Eisai launch Alzheimer's drug Leqembi in China
Jun 28 BIIB Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
Jun 28 BIIB Eisai and Biogen launch Alzheimer's drug Leqembi in China
Jun 27 BIIB “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
Jun 27 REGN Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
Jun 27 HALO Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Jun 26 REGN Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
Jun 26 AZN AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Monoclonal Antibodies

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.

Browse All Tags